J. Longshore

发表

Recovery and Phylogenetic Analysis ofnifH Sequences from Diazotrophic Bacteria Associated with Dead Aboveground Biomass of Spartina alterniflora

Michael J. Friez, M. Friez, C. R. Lovell, 2001, Applied and Environmental Microbiology.

PD‐L1 Immunohistochemistry Assays for Lung Cancer: Results from Phase 1 of the Blueprint PD‐L1 IHC Assay Comparison Project

F. Hirsch, K. Kerr, M. Tsao, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Implementing TMB measurement in clinical practice: considerations on assay requirements

F. López-Ríos, F. Penault-Llorca, N. Normanno, 2019, ESMO Open.

Evidence that a dodecamer duplication in the gene HOPA in Xq13 is not associated with mental retardation

R. Stevenson, C. Schwartz, M. Friez, 1999, Human Genetics.

A retrospective analysis of the clinical performance of human papillomavirus testing using SurePath sample collection.

C. Livasy, J. Longshore, J. Symanowski, 2014, Journal of the American Society of Cytopathology.

American College of Medical Genetics Statement on Diagnostic Testing for Uniparental Disomy

D. Ledbetter, L. Shaffer, J. Longshore, 2001, Genetics in medicine : official journal of the American College of Medical Genetics.

BRAF p.V600E immunohistochemistry in challenging samples: about false-positive and false-negative results--reply.

C. Cohen, J. Longshore, J. Palma, 2015, Human pathology.

Accelerating the Development and Validation of Liquid Biopsy for Early Cancer Screening and Treatment Tailoring

F. Gatto, T. Čufer, D. Verbanac, 2022, Healthcare.

Multiplex testing for Factor II and Factor V mutations in thrombophilia: technical verification and clinical validation of the cobas® Factor II and Factor V test

J. Longshore, S. Karwowska, Guili Zhang, 2018, Journal of Thrombosis and Thrombolysis.

Localization of human elav-like neuronal protein 1 (Hel-N1) on chromosome 9p21 by chromosome microdissection polymerase chain reaction and fluorescence in situ hybridization.

J. Longshore, P. King, J. Han, 1996, Genomics.

Ciliary dyskinesia associated with hydrocephalus and mental retardation in a Jordanian family.

J. Longshore, A. Karnik, F. Khan, 2001, Mayo Clinic proceedings.

Instability of the FMR2 trinucleotide repeat region associated with expanded FMR1 alleles.

J. Longshore, M. Descartes, J. Tarleton, 1997, American journal of medical genetics.

A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee

A. Nicholson, A. Borczuk, I. Wistuba, 2020, Journal of Thoracic Oncology.

PD-L1 Testing for Lung Cancer in 2019: Perspective from the IASLC Pathology Committee.

N. Girard, A. Nicholson, A. Borczuk, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology Committee

A. Nicholson, A. Borczuk, I. Wistuba, 2020, Journal of Thoracic Oncology.

Programmed Death-Ligand 1 Immunohistochemistry Testing: A Review of Analytical Assays and Clinical Implementation in Non-Small-Cell Lung Cancer.

K. Bloom, M. Dietel, K. Kerr, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

IASLC Global Survey on PD-L1 Testing for Non-Small Cell Lung Cancer.

N. Le Stang, A. Nicholson, A. Borczuk, 2021, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Over-representation of the disease associated (CAG) and (CGG) repeats in the human genome.

J. Longshore, J Han, W H Finley, 1994, Nucleic acids research.

X chromosome-inactivation patterns of 1,005 phenotypically unaffected females.

H. Willard, C. Schwartz, A. Cottle, 2006, American journal of human genetics.

Tissue‐specific methylation differences in a fragile X premutation carrier

F. Tassone, J. Longshore, Annette K. Taylor, 1999, Clinical genetics.

Expansion of the fragile X CGG repeat in females with premutation or intermediate alleles.

W. Brown, J. Mandel, H. Hjalgrim, 2003, American journal of human genetics.

Dynamic mutations in human genes: A review of trinucleotide repeat diseases

J. Longshore, J. Tarleton, 1996, Journal of Genetics.

Evidence that a dodecamer duplication in the gene HOPA in Xq13 is not associated with mental retardation.

R. Stevenson, C. Schwartz, M. Friez, 2000 .

Molecular Testing for Treatment of Metastatic Non-Small Cell Lung Cancer: How to Implement Evidence-Based Recommendations.

I. Wistuba, F. Hirsch, S. Ou, 2015, The oncologist.

Accurate detection of BRAF p.V600E mutations in challenging melanoma specimens requires stringent immunohistochemistry scoring criteria or sensitive molecular assays.

C. Cohen, J. Longshore, M. Siddiqui, 2014, Human pathology.

Molecular diversity of diazotrophs in oligotrophic tropical seagrass bed communities.

Shawn W. Polson, M. Friez, C. R. Lovell, 2002, FEMS microbiology ecology.

Tumor Mutation Burden: Promises and Challenges A Perspective from the IASLC Pathology Committee.

A. Nicholson, A. Borczuk, I. Wistuba, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

A Grading system for invasive pulmonary adenocarcinoma: a proposal from the IASLC pathology committee.

A. Nicholson, A. Borczuk, I. Wistuba, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

P2.09-24 IASLC Global Survey for Pathologists on PD-L1 Testing for Non-Small Cell Lung Cancer

A. Nicholson, A. Borczuk, Guoan Chen, 2019, Journal of Thoracic Oncology.

The HOPA Gene Dodecamer Duplication Is Not a Significant Etiological Factor in Autism

C. Skinner, R. Stevenson, M. Friez, 2000, Journal of autism and developmental disorders.

FMR1 CGG expansion to full mutation: What is the lower limit in premutation females?

W. Brown, J. Mandel, H. Hjalgrim, 2000 .

The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology Committee

A. Nicholson, A. Borczuk, I. Wistuba, 2020 .

Comparison of Molecular Testing Methods for Detecting BRAF V600 Mutations in Melanoma Specimens with Challenging Attributes

J. Longshore, J. Palma, G. Hillman, 2015 .